Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharmilee Gnanapavan

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Multiple Sclerosis and Related Disorders|June 14, 2021
Can rheumatologists stop causing demyelinating disease?David Baker, Charalambos Hadjicharalambous, Sharmilee Gnanapavan, et al.
Multiple Sclerosis and Related Disorders|March 8, 2025
Clinical opinions and case studies on understanding and managing hypogammaglobulinaemia in multiple sclerosis: United Kingdom perspectiveSharmilee Gnanapavan, Angray Kang, David Baker, et al.
Frontiers in Neuroscience|April 23, 2021
The Evolution of Neurofilament Light Chain in Multiple SclerosisCarolina Ferreira-Atuesta, Saúl Reyes, Gavin Giovanonni, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 22, 2020
Sequential interleukin 2 and pembrolizumab use in progressive multifocal leukoencephalopathyChristoph Mahler, Michael Andrews, Sian M Henson, et al.
Neurology|July 2, 2020
Teaching NeuroImages: Rare skull base involvement in neurosarcoidosisChristoph Friedrich Mahler, Ashok Adams, Krishna Suchak, et al.
Cureus|February 6, 2026
A Lyme Neuroborreliosis Case Presenting With Ophthalmoplegia, Dysarthria, and Spastic QuadriparesisMaria Sklirou, Mohammad Aboulwafaali, Anusha Karunasagar, et al.
BMC Neurology|April 4, 2014
A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndromeSharmilee Gnanapavan, Zane Jaunmuktane, Kelly Pegoretti Baruteau, et al.
Multiple Sclerosis and Related Disorders|July 7, 2019
Plasma cell and B cell-targeted treatments for use in advanced multiple sclerosisDavid Baker, Benjamin M Jacobs, Sharmilee Gnanapavan, et al.
Practical Neurology|December 11, 2017
Cryptococcal meningitis in apparently immunocompetent patients: association with idiopathic CD4+ lymphopeniaSamuel Shribman, Alastair Noyce, Sharmilee Gnanapavan, et al.
Multiple Sclerosis and Related Disorders|October 8, 2021
Antigen-specific tolerization in human autoimmunity: Inhibition of interferon-beta1a anti-drug antibodies in multiple sclerosis: A case reportMonica Marta, David Baker, Paul Creeke, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Multiple Sclerosis and Related Disorders|June 14, 2021
Can rheumatologists stop causing demyelinating disease?David Baker, Charalambos Hadjicharalambous, Sharmilee Gnanapavan, et al.
Multiple Sclerosis and Related Disorders|March 8, 2025
Clinical opinions and case studies on understanding and managing hypogammaglobulinaemia in multiple sclerosis: United Kingdom perspectiveSharmilee Gnanapavan, Angray Kang, David Baker, et al.
Frontiers in Neuroscience|April 23, 2021
The Evolution of Neurofilament Light Chain in Multiple SclerosisCarolina Ferreira-Atuesta, Saúl Reyes, Gavin Giovanonni, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 22, 2020
Sequential interleukin 2 and pembrolizumab use in progressive multifocal leukoencephalopathyChristoph Mahler, Michael Andrews, Sian M Henson, et al.
Neurology|July 2, 2020
Teaching NeuroImages: Rare skull base involvement in neurosarcoidosisChristoph Friedrich Mahler, Ashok Adams, Krishna Suchak, et al.
Cureus|February 6, 2026
A Lyme Neuroborreliosis Case Presenting With Ophthalmoplegia, Dysarthria, and Spastic QuadriparesisMaria Sklirou, Mohammad Aboulwafaali, Anusha Karunasagar, et al.
BMC Neurology|April 4, 2014
A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndromeSharmilee Gnanapavan, Zane Jaunmuktane, Kelly Pegoretti Baruteau, et al.
Multiple Sclerosis and Related Disorders|July 7, 2019
Plasma cell and B cell-targeted treatments for use in advanced multiple sclerosisDavid Baker, Benjamin M Jacobs, Sharmilee Gnanapavan, et al.
Practical Neurology|December 11, 2017
Cryptococcal meningitis in apparently immunocompetent patients: association with idiopathic CD4+ lymphopeniaSamuel Shribman, Alastair Noyce, Sharmilee Gnanapavan, et al.
Multiple Sclerosis and Related Disorders|October 8, 2021
Antigen-specific tolerization in human autoimmunity: Inhibition of interferon-beta1a anti-drug antibodies in multiple sclerosis: A case reportMonica Marta, David Baker, Paul Creeke, et al.
Pageof 8